Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis
ObjectiveThe current study was designed with the aim of conducting a systematic review and meta-analysis to determine the circulating levels of visfatin in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals.MethodsUntil March 2024, we searched the Web of Scien...
Main Authors: | Nahid Aboutaleb, Alireza Moradi, Hamzeh Mirshekari Jahangiri, Mohammad Reza Aslani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1432025/full |
Similar Items
-
Serum levels of visfatin, sirtuin-1, and interleukin-6 in stable and acute exacerbation of chronic obstructive pulmonary disease
by: Hassan Ghobadi, et al.
Published: (2021-01-01) -
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
by: Anna Maria Cybulska, et al.
Published: (2025-02-01) -
Circulating endothelial cells and serum visfatin are indicators of cardiovascular disease risk in psoriasis patients
by: Lamia Elgarhy, et al.
Published: (2016-03-01) -
Tissue Expression of Visfatin in Psoriatic Patients
by: Abd El-Aziz El-Rifaie, et al.
Published: (2022-10-01) -
Breastfeeding effects on visfatin levels in postpartum women
by: Ching-Ju Shen, et al.
Published: (2015-06-01)